Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 2
2011 2
2012 6
2013 10
2014 7
2015 9
2016 7
2017 8
2018 8
2019 14
2020 11
2021 6
2022 3
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Results by year

Filters applied: . Clear all
Page 1
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.
Motzer RJ, Tannir NM, McDermott DF, Arén Frontera O, Melichar B, Choueiri TK, Plimack ER, Barthélémy P, Porta C, George S, Powles T, Donskov F, Neiman V, Kollmannsberger CK, Salman P, Gurney H, Hawkins R, Ravaud A, Grimm MO, Bracarda S, Barrios CH, Tomita Y, Castellano D, Rini BI, Chen AC, Mekan S, McHenry MB, Wind-Rotolo M, Doan J, Sharma P, Hammers HJ, Escudier B; CheckMate 214 Investigators. Motzer RJ, et al. N Engl J Med. 2018 Apr 5;378(14):1277-1290. doi: 10.1056/NEJMoa1712126. Epub 2018 Mar 21. N Engl J Med. 2018. PMID: 29562145 Free PMC article. Clinical Trial.
Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer.
Fizazi K, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I, Kappeler C, Snapir A, Sarapohja T, Smith MR; ARAMIS Investigators. Fizazi K, et al. N Engl J Med. 2019 Mar 28;380(13):1235-1246. doi: 10.1056/NEJMoa1815671. Epub 2019 Feb 14. N Engl J Med. 2019. PMID: 30763142 Clinical Trial.
Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer.
Smith MR, Saad F, Chowdhury S, Oudard S, Hadaschik BA, Graff JN, Olmos D, Mainwaring PN, Lee JY, Uemura H, Lopez-Gitlitz A, Trudel GC, Espina BM, Shu Y, Park YC, Rackoff WR, Yu MK, Small EJ; SPARTAN Investigators. Smith MR, et al. N Engl J Med. 2018 Apr 12;378(15):1408-1418. doi: 10.1056/NEJMoa1715546. Epub 2018 Feb 8. N Engl J Med. 2018. PMID: 29420164 Free article. Clinical Trial.
Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide.
Fizazi K, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I, Le Berre MA, Petrenciuc O, Snapir A, Sarapohja T, Smith MR; ARAMIS Investigators. Fizazi K, et al. N Engl J Med. 2020 Sep 10;383(11):1040-1049. doi: 10.1056/NEJMoa2001342. N Engl J Med. 2020. PMID: 32905676 Clinical Trial.
Énucléation versus orchidectomie totale dans la prise en charge des tumeurs testiculaires à cellules de Leydig : résultats d'une étude multicentrique rétrospective.
Laclergerie F, Mouillet G, Larre S, Eschwege P, Hubert J, Saussine C, Cormier L, Thiery-Vuillemin A, Kleinclauss F. Laclergerie F, et al. Among authors: mouillet g. Prog Urol. 2015 Nov;25(13):855-6. doi: 10.1016/j.purol.2015.08.281. Prog Urol. 2015. PMID: 26544473 French. No abstract available.
[Metastatic renal cell carcinoma: Management of toxicities of combinations].
Joly F, Michot JM, Dourthe LM, Fléchon A, Mahammedi H, Maillet D, Mouillet G, Pouessel D, Rolland F, Topart D, Albiges L. Joly F, et al. Among authors: mouillet g. Bull Cancer. 2022 Jul-Aug;109(7-8):844-861. doi: 10.1016/j.bulcan.2022.04.019. Epub 2022 Jun 21. Bull Cancer. 2022. PMID: 35738914 Review. French.
[Relapse surveillance of patients with testicular germ cell tumor].
Orillard E, Klajer E, Kalbacher E, Joly F, David A, Hervé L, Viot J, Mouillet G, Barkatz J, Kleinclauss F, Thiery-Vuillemin A. Orillard E, et al. Among authors: mouillet g. Bull Cancer. 2019 Oct;106(10):903-914. doi: 10.1016/j.bulcan.2019.06.006. Epub 2019 Sep 5. Bull Cancer. 2019. PMID: 31495441 Review. French.
[Systemic treatment of locally advanced or metastatic penile cancer].
Gassian N, Frontczak A, El Kaddissi A, Calcagno F, Almotlak H, Barkatz J, Mouillet G, Maurina T, Stein U, Nguyen Tan Hon T, Murez T, Thiery-Vuillemin A. Gassian N, et al. Among authors: mouillet g. Bull Cancer. 2020 Jun;107(5S):S17-S23. doi: 10.1016/S0007-4551(20)30274-5. Bull Cancer. 2020. PMID: 32620202 Review. French.
Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial.
Silvain J, Lattuca B, Beygui F, Rangé G, Motovska Z, Dillinger JG, Boueri Z, Brunel P, Lhermusier T, Pouillot C, Larrieu-Ardilouze E, Boccara F, Labeque JN, Guedeney P, El Kasty M, Laredo M, Dumaine R, Ducrocq G, Collet JP, Cayla G, Blanchart K, Kala P, Vicaut E, Montalescot G; ALPHEUS investigators. Silvain J, et al. Lancet. 2020 Nov 28;396(10264):1737-1744. doi: 10.1016/S0140-6736(20)32236-4. Epub 2020 Nov 14. Lancet. 2020. PMID: 33202219 Free article. Clinical Trial.
Impact of open-label versus blinded study design on patient-reported outcomes data in randomized clinical trials of immunotherapy in advanced or metastatic cancer patients: a systematic review.
Anota A, Pozet A, Lemasson H, Cotté FE, Falcoz A, Eberst G, Mouillet G, Guerzider S, Charton É, Westeel V. Anota A, et al. Among authors: mouillet g. Qual Life Res. 2022 Mar;31(3):645-657. doi: 10.1007/s11136-021-02945-8. Epub 2021 Jul 20. Qual Life Res. 2022. PMID: 34283382 Review.
83 results